architectural proteins |
proteins playing a structural role in chromatin organization, include linker and core histone proteins and insulator proteins |
acetylated histone protein |
an epigenetic marker; an indicator of transcriptional competence |
BBB |
blood–brain barrier |
BDNF |
brain-derived neurotrophic factor |
BETi(s) |
BET inhibitor(s) of transcription factors of the BRD family |
BRD |
bromodomain [bromo- and extra-terminal motif (BET) domains] family of proteins (BRD1, BRD2, BRD3, BRD4, and BRDT) that bind to acetylated histone and promote the recruitment of macromolecular complexes with an increase in DNA transcriptional competence; belong to the functional class of readers |
CB1 |
cannabinoid receptor 1 |
CBP |
cyclic adenosine monophosphate response element-binding protein [CREB-binding protein]; transcriptional coactivator |
CCL2 |
C-C motif ligand 2; chemokine |
ChIP |
chromatin immunoprecipitation; protocols for profiling chemical modification of chromatin using immunoprecipitating methods |
chromatin accessibility |
the degree to which nuclear macromolecules are able to physically contact chromatinized DNA and is determined by the occupancy and topological organization of nucleosomes and other chromatin-binding factors that regulate access to the DNA |
chromatin-binding factors |
non-histone macromolecules binding to DNA (either directly or indirectly) |
CNS |
central nervous system |
CpG |
cytosine–guanine site; a dinucleotide sequence subject to preferred methylation; CpG sequences are predominantly concentrated in non-coding regions of the genome (CpG islands [CpG island]) and are associated with promoter DNA regions |
CRP |
C-reactive protein |
CXCL1/10 |
C-X-C motif ligand 1/10; chemokine |
DNA |
deoxyribonucleic acid |
DNMT |
DNA methyltransferase; methyltransferase of the DNMT3a type is represented by several isoforms and is responsible for de novo methylation, and DNMT1 (and DNMT3b)—interact with methylated loci; DNMT belongs to the functional class of writers |
DNMTi(s) |
DNMT inhibitor(s) |
enhancer |
a non-coding regulatory region of DNA, which, after binding of transcription factors to it, stimulates gene transcription |
epigenome (epigenetic landscape) |
a set of epigenetic phenomena in a cell at the estimated time |
euchromatin |
areas of decondensed, transcriptionally competent state of chromatin |
EWASs |
epigenome-wide association studies |
GWASs |
genome-wide association studies |
H |
histone proteins (H2A, H2B, H3, H4), constituting, in the form of dimers, a nucleosome complex |
HAT |
histone acetyltransferase; belongs to the functional group of writers; in general, HAT increases gene expression |
HATi(s) |
HAT inhibitor(s) |
HDAC |
histone deacetylase; HDACs are epigenetic erasers and make the DNA less accessible to transcription factors; the HDAC family includes zinc-dependent enzymes of the HDACI, HDACII, HDACIV, and NAD+-dependent HDACIII classes (sirtuins, SIRT) |
HDACi(s) |
HDAC inhibitor(s) |
heterochromatin |
areas of condensed, transcriptionally incompetent state of chromatin (DNA and histone proteins) |
HIF1 |
hypoxia-inducible factor 1 |
IGF2 |
insulin-like growth factor 2 |
IL-6 |
interleukin-6; has both pro- and anti-inflammatory activities depending on the tissue type |
insulator |
a non-coding protein-binding regulatory DNA sequence that regulates inter-chromosomal (enhancer-blocking insulators) and intra-chromosomal (barrier to the spread of neighboring heterochromatin) interactions within a particular DNA locus, flanked by insulators |
KDM |
lysine-specific demethylase [lysine demethylase]; KDM belongs to the functional class of erasers |
KDMi(s) |
KDM inhibitor(s) |
KMT |
lysine histone methyltransferase; KMT belongs to the functional class of writers |
KMTi(s) |
KMT inhibitor(s) |
MAO B |
monoamine oxidase B |
MMP9 |
matrix metalloproteinase 9 |
methylated cytosine DNA (5mC, 5-methylcytosine) |
epigenetic marker; an indicator of transcriptional incompetence; 5hmC—5-hydroxymethylcytosine, derivative of 5mC acting in further oxidation |
ncRNA |
non-coding functionally active RNA sequences [non-coding RNA]; the most important regulators of the epigenome are microRNAs [miRNAs], enhancer and long-length non-coding RNAs [eRNAs and lncRNAs] |
NGF |
nerve growth factor |
NGS |
next-generation sequencing; massively parallel DNA and RNA sequencing methods providing ultra-high throughput, scalability, and speed of analysis |
nucleosome (complex) |
the main structure-forming element of chromatin, an octamer of histone proteins encircled by approximately 147 DNA bp; together the composition and post-translational modification of nucleosomes regulate chromatin accessibility |
p75(NTR) |
p75 neurotrophin receptor, mediating a set of signaling pathways, including caspase-dependent signaling |
PCAF |
p300/CBP-associated factor, regulates crosstalk-dependent acetylation of histone H3 by distal site recognition |
PGC1α |
peroxisome proliferator-activated receptor gamma coactivator 1-alpha; transcriptional coactivator |
PK/PD |
pharmacokinetics and pharmacodynamics |
PPARδ |
peroxisome proliferator-activated receptor delta; nuclear hormone receptor |
promoter |
non-coding DNA region that binds to RNA polymerase and helper proteins initiating the transcription |
PUFA(s) |
polyunsaturated fatty acid(s) |
RNA |
ribonucleic acid |
ROS |
reactive oxygen species |
STAT3 |
signal transducer and activator of transcription 3 |
TAD |
topologically associated domain; a genomic region that self-interacts to form a three-dimensional structure, which determines the possibility of active interaction of regulatory elements (promoter–enhancer loops) and the transcriptional competence of a particular DNA locus |
TF(s) |
transcription factor(s); non-histone protein(s) binding directly to DNA and controlling the transcription rates |
TET proteins |
ten-eleven translocation proteins; enzymes that hydroxylate methylated cytosine (5mC); TET proteins belong to the functional class of erasers |
TNF-α |
tumor necrosis factor alpha; cytokine |